A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)

PurposeThe present study aimed to develop and validate a preoperative model based on gadobenate-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) size of ≤5 cm. In order to provide preoperative guidance for clinician...

Full description

Bibliographic Details
Main Authors: Sisi Zhang, Lei Huo, Juan Zhang, Yayuan Feng, Yiping Liu, Yuxian Wu, Ningyang Jia, Wanmin Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.992301/full
_version_ 1811285716385136640
author Sisi Zhang
Lei Huo
Juan Zhang
Yayuan Feng
Yiping Liu
Yuxian Wu
Ningyang Jia
Wanmin Liu
author_facet Sisi Zhang
Lei Huo
Juan Zhang
Yayuan Feng
Yiping Liu
Yuxian Wu
Ningyang Jia
Wanmin Liu
author_sort Sisi Zhang
collection DOAJ
description PurposeThe present study aimed to develop and validate a preoperative model based on gadobenate-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) size of ≤5 cm. In order to provide preoperative guidance for clinicians to optimize treatment options.Methods164 patients with pathologically confirmed HCC and preoperative gadobenate-enhanced MRI from July 2016 to December 2020 were retrospectively included. Univariate and multivariate logistic regression (forward LR) analyses were used to determine the predictors of MVI and the model was established. Four-fold cross validation was used to verify the model, which was visualized by nomograms. The predictive performance of the model was evaluated based on discrimination, calibration, and clinical utility.ResultsElevated alpha-fetoprotein (HR 1.849, 95% CI: 1.193, 2.867, P=0.006), atypical enhancement pattern (HR 3.441, 95% CI: 1.523, 7.772, P=0.003), peritumoral hypointensity on HBP (HR 7.822, 95% CI: 3.317, 18.445, P<0.001), and HBP hypointensity (HR 3.258, 95% CI: 1.381, 7.687, P=0.007) were independent risk factors to MVI and constituted the HBP model. The mean area under the curve (AUC), sensitivity, specificity, and accuracy values for the HBP model were as follows: 0.830 (95% CI: 0.784, 0.876), 0.71, 0.78, 0.81 in training set; 0.826 (95% CI:0.765, 0.887), 0.8, 0.7, 0.79 in test set. The decision curve analysis (DCA) curve showed that the HBP model achieved great clinical benefits.ConclusionIn conclusion, the HBP imaging features of Gd-BOPTA-enhanced MRI play an important role in predicting MVI for HCC. A preoperative model, mainly based on HBP imaging features of gadobenate-enhanced MRI, was able to excellently predict the MVI for HCC size of ≤5cm. The model may help clinicians preoperatively assess the risk of MVI in HCC patients so as to guide clinicians to optimize treatment options.
first_indexed 2024-04-13T02:48:12Z
format Article
id doaj.art-fa96a5c8063642858d30cec7344dd0e6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T02:48:12Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-fa96a5c8063642858d30cec7344dd0e62022-12-22T03:05:56ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.992301992301A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)Sisi Zhang0Lei Huo1Juan Zhang2Yayuan Feng3Yiping Liu4Yuxian Wu5Ningyang Jia6Wanmin Liu7Department of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaPurposeThe present study aimed to develop and validate a preoperative model based on gadobenate-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) size of ≤5 cm. In order to provide preoperative guidance for clinicians to optimize treatment options.Methods164 patients with pathologically confirmed HCC and preoperative gadobenate-enhanced MRI from July 2016 to December 2020 were retrospectively included. Univariate and multivariate logistic regression (forward LR) analyses were used to determine the predictors of MVI and the model was established. Four-fold cross validation was used to verify the model, which was visualized by nomograms. The predictive performance of the model was evaluated based on discrimination, calibration, and clinical utility.ResultsElevated alpha-fetoprotein (HR 1.849, 95% CI: 1.193, 2.867, P=0.006), atypical enhancement pattern (HR 3.441, 95% CI: 1.523, 7.772, P=0.003), peritumoral hypointensity on HBP (HR 7.822, 95% CI: 3.317, 18.445, P<0.001), and HBP hypointensity (HR 3.258, 95% CI: 1.381, 7.687, P=0.007) were independent risk factors to MVI and constituted the HBP model. The mean area under the curve (AUC), sensitivity, specificity, and accuracy values for the HBP model were as follows: 0.830 (95% CI: 0.784, 0.876), 0.71, 0.78, 0.81 in training set; 0.826 (95% CI:0.765, 0.887), 0.8, 0.7, 0.79 in test set. The decision curve analysis (DCA) curve showed that the HBP model achieved great clinical benefits.ConclusionIn conclusion, the HBP imaging features of Gd-BOPTA-enhanced MRI play an important role in predicting MVI for HCC. A preoperative model, mainly based on HBP imaging features of gadobenate-enhanced MRI, was able to excellently predict the MVI for HCC size of ≤5cm. The model may help clinicians preoperatively assess the risk of MVI in HCC patients so as to guide clinicians to optimize treatment options.https://www.frontiersin.org/articles/10.3389/fonc.2022.992301/fullgadobenate dimegluminehepatocellular carcinomamicrovascular invasionmagnetic resonance imagingnomogram
spellingShingle Sisi Zhang
Lei Huo
Juan Zhang
Yayuan Feng
Yiping Liu
Yuxian Wu
Ningyang Jia
Wanmin Liu
A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
Frontiers in Oncology
gadobenate dimeglumine
hepatocellular carcinoma
microvascular invasion
magnetic resonance imaging
nomogram
title A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
title_full A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
title_fullStr A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
title_full_unstemmed A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
title_short A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
title_sort preoperative model based on gadobenate enhanced mri for predicting microvascular invasion in hepatocellular carcinomas ≤ 5 cm
topic gadobenate dimeglumine
hepatocellular carcinoma
microvascular invasion
magnetic resonance imaging
nomogram
url https://www.frontiersin.org/articles/10.3389/fonc.2022.992301/full
work_keys_str_mv AT sisizhang apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT leihuo apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT juanzhang apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT yayuanfeng apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT yipingliu apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT yuxianwu apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT ningyangjia apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT wanminliu apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT sisizhang preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT leihuo preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT juanzhang preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT yayuanfeng preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT yipingliu preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT yuxianwu preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT ningyangjia preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm
AT wanminliu preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm